Gagnon Securities’s CM Life Sciences, Inc. Unit CMLFU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-656,269
Closed -$10.3M 117
2021
Q2
$10.3M Sell
656,269
-67
-0% -$969 1.47% 26
2021
Q1
$10.8M Buy
656,336
+31,754
+5% +$557K 1.64% 22
2020
Q4
$7.25M Buy
624,582
+170,378
+38% +$1.84M 1.15% 26
2020
Q3
$4.76M Buy
+454,204
New +$4.78M 1.01% 28

Gagnon Securities's CMLFU Position: Q3 2021 in Review

Gagnon Securities sold out of CM Life Sciences, Inc. Unit (CMLFU) in Q3 2021, closing a stake of 656,269 shares — an estimated $10.3M sold.

Gagnon Securities first reported a position in CMLFU in Q3 2020 and held it in 4 quarters. The position peaked at $10.8M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMLFU as of Q3 2021.

  • Gagnon Securities reported no remaining CM Life Sciences, Inc. Unit position as of Q3 2021 after selling out during the quarter.
  • Gagnon Securities sold 656,269 CM Life Sciences, Inc. Unit shares in Q3 2021, an estimated $10.3M.
  • Gagnon Securities first reported a position in CM Life Sciences, Inc. Unit in Q3 2020 and held it in 4 quarters.
  • Gagnon Securities's CM Life Sciences, Inc. Unit position peaked at $10.8M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held CM Life Sciences, Inc. Unit as of Q3 2021.

Based on Gagnon Securities's 13F filing for Q3 2021, filed 12 Nov 2021.